Neurologia i Neurochirurgia Polska

Papers
(The TQCC of Neurologia i Neurochirurgia Polska is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Safety, efficacy and steroid-sparing effect of amifampridine in Lambert-Eaton myasthenic syndrome patients — real world data41
Haemorrhagic intracranial complications associated with vaccine-induced thrombocytopenia or central venous thrombosis after COVID-19 vaccination: postulated underlying mechanisms with literature and c35
Recurrence of cerebrospinal fluid-venous fistulas at different spinal levels following transvenous embolisation or blood/fibrin glue patching25
LRRK2 R1441C mutation causing Parkinson’s Disease in an Egyptian family24
Mechanical thrombectomy in very elderly people: shortand long-term outcomes of endovascular stroke treatment in nonagenarians24
Relevance of admission hyperglycaemia and diabetes mellitus to efficacy and safety of mechanical thrombectomy in stroke patients23
C9orf72 hexanucleotide repeat expansion found in suspected spinobulbar muscular atrophy (SBMA)23
Deep brain stimulation of hippocampus in treatment of refractory temporal lobe epilepsy16
Importance of hypoglycemia episodes and glycemic variability in parkinsonian syndromes15
Response to ‘Neuro-COVID due to the response against the virus’ Letter14
Sex-related patient-reported brain fog symptoms in non-hospitalised COVID-19 patients14
Does ASTRAL score at hospital admission predict symptomatic haemorrhagic transformation in acute ischaemic stroke after revascularisation? A pilot single-centre study13
Ambiguities in blood pressure management in acute ischaemic stroke13
Predictors for long-term incomplete nidus obliteration following stereotactic radiosurgery for brain arteriovenous malformations: a systematic review and meta-analysis13
Multisystem presentation of Late Onset Pompe Disease: what every consulting neurologist should know11
Common therapeutic approaches in sleep and awake bruxism — an overview11
Response to Letter to the Editors entitled ‘Neurotoxicity of levodopa/carbidopa intestinal gel preparations can cause polyneuropathy in Parkinson‘s patients‘10
Does botulinum toxin type A treatment influence non-motor symptoms in cervical dystonia patients? A systematic review10
Risk factors for reoperation after surgical treatment for degenerative spinal disease in Poland: a nationwide retrospective study of 38,953 hospitalisations9
Management of autoimmune temporal lobe epilepsy with GAD65 antibody: four case reports9
Paraneoplastic cerebellar degeneration — raising awareness for early diagnosis9
From rarity to reality: Poland’s first case of neurological Erdheim-Chester Disease with cerebellar manifestations8
Latest bibliometrics of Polish Journal of Neurology and Neurosurgery8
Excessive supraventricular activity and risk of atrial fibrillation in patients with cryptogenic ischaemic stroke8
Response to ‘Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out’8
Predicting haemorrhagic transformation through serum biochemical indices for patients after endovascular treatment: a retrospective study8
Response to ‘Neurologists should retain diagnostic and therapeutic management of migraines’8
Screening for PRKN and PINK1 mutations in Ecuadorian patients with early-onset Parkinson’s Disease7
Cognitive impairment in chronic migraine compared to pseudotumor cerebri7
Prevalence of ruptured small and very small aneurysms: a retrospective single-centre study7
Unruptured intracranial aneurysm volume change patterns and association with age, sex, location in vascular tree, and common risk factors: a single-centre retrospective study7
Safety and efficacy of short percutaneous fixation in AO3 and AO4 lumbar fractures: a single-centre experience of 35 cases7
Choroid plexus imaging in multiple sclerosis management — a systematic review7
Fatigue in people with Parkinson’s disease — its scale and consequences for activity and quality of life7
Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases6
Challenges of equitable access to device-aided therapies for advanced Parkinson’s Disease in Poland — expert consensus and treatment recommendations6
Course of fatigue among patients previously hospitalised due to COVID-196
Acute-onset chorea and confusional state in 77-year-old COVID-19 patient: a case report6
Herpes zoster prevention in multiple sclerosis and neuromyelitis optica spectrum disorders6
Neurologists should retain diagnostic and therapeutic management of migraines6
Clinical and radiological consequences of delayed therapy escalation in patients with relapsing-remitting multiple sclerosis6
Cerebrovascular events — from transient ischemic attack and transient global amnesia to transient ischemic attack with MRI-DWI lesions6
Response to: DNAJC30 variants can also manifest phenotypically as Leigh/LHON overlap syndrome6
Rowland Payne syndrome mimicking motor neuron disease6
Migraine in the elderly — diagnosis and treatment: a single-centre experience6
Heart Rate Variability in evaluation of autonomic dysfunction in idiopathic REM-sleep behaviour disorder6
Effects of idebenone treatment in a patient with DNAJC30-associated Leigh Syndrome6
Erdheim-Chester disease is often complicated by neurological disorders6
Differences in prevalence of orthostatic hypotension between Parkinson’s Disease motor subtypes6
Treatment of the traumatic spine dislocation C6-7 and SCIWORA Th11 in 11-years old girl5
Differences in subcortical functional connectivity in patients with epilepsy5
Echocardiographic evaluation of cardiac function in patients with myotonic dystrophy — is the right ventricular dysfunction observed? One academic center experience5
Elevated tissue factor pathway inhibitor is associated with intracerebral haemorrhage of unknown cause in young adults5
Effect of levetiracetam on nocturnal sleep in patients with epilepsy5
Is deep brain stimulation effective in Huntington’s Disease? — a systematic literature review5
Is remission in women with idiopathic generalized epilepsy possible without valproate?5
Biomarkers of functional movement disorders — a systematic review5
Olfactory dysfunction in patients with Wilson’s Disease4
Carbohydrate metabolism and lipid profile in patients with Parkinson’s disease with subthalamic deep brain stimulation4
Do Parkinson’s Disease clinical subtypes really exist?4
Blood-brain barrier-associated serum proteins in epilepsy — clinical and diagnostic implications4
Reperfusion therapy of ischaemic strokes in oral anticoagulated patients: an expanding field in clinical practice4
Clinical, serological, and electrophysiological differences in chronic inflammatory demyelinating polyradiculoneuropathy patients with and without malignancy — real-life evidence4
Response to the Letter to the Editors on the article reviewing the complex subject of ‘Impact of SARS-CoV-2 on the nervous system’4
Patterns of antiseizure medication use in pregnant women with epilepsy: a 24-year observation in Poland4
Prognostic significance of age in patients with acute ischaemic stroke treated with intravenous thrombolysis4
Polish recommendations for diagnosis and therapy of paediatric stroke4
Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes4
Overlapping challenges of treating cerebrospinal fluid dynamic disorders4
Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society4
Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke — a single centre experience4
Acute kidney injury negatively affects short and long-term outcomes of mechanical thrombectomy in acute ischaemic stroke4
Ophthalmological abnormalities observed in two patients with Gerstmann–Sträussler–Scheinker disease4
Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS)4
Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic4
Autonomous extraction of preoperative radiographic predictors on X-ray for cervical spine deformity following laminoplasty: a prospectively validated AI tool4
Two cases of delayed onset, fully reversible cortical oedema and signal intensity on brain MRI without infarction caused by prolonged migraine aura4
Open imaging protocols, amyotrophic lateral sclerosis and other neurodegenerative disorders4
Impact of treatment on blood-brain barrier impairment in Wilson’s disease4
Clinical, immunological and neuroimaging spectrum of CNS lupus: can we reliably differentiate it from MS?4
SARS-CoV-2 infection complicated by neuro- or psycho-COVID4
Tardive dystonia in Gilles de la Tourette syndrome — a single center experience4
Comparison of autonomic dysfunction in patients with Parkinson’s Disease, progressive supranuclear palsy, and multiple system atrophy4
Serotonin syndrome: understanding pathophysiological bases and managing a growing clinical challenge4
Deep brain stimulation of anterior nucleus and centromedian nucleus of thalamus in treatment for drug-resistant epilepsy3
Clinical and neuroradiological red flags in differential diagnosis of pituitary metastases and PitNETs (adenomas): a surgeon’s experience and systematic literature review3
Vocational activity for patients with multiple sclerosis3
Surgical treatment of brainstem cavernomas using diffusion tensor imaging and diffusion tensor tractography3
Parkinson’s Disease and glucose dysregulation: shared pathophysiological mechanisms and clinical implications3
Differences in diffusion tensor imaging parameters of brain white matter tracts between patients with myotonic dystrophy type 1 and type 2 — a retrospective single-centre study3
Is target-controlled infusion better than manual controlled infusion during TIVA for elective neurosurgery? Results of a single-centre pilot study3
Clinical significance and prognostic value of serum autoantibody tests in multiple sclerosis3
COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study3
Before headache in upper respiratory tract infection can be attributed to immune response, it must be quantified and causative virus identified3
Long-term cenobamate retention, efficacy, and safety: outcomes from Expanded Access Programme3
Response to Letter to the Editors regarding article entitled ‘Left ventricular non-compaction cardiomyopathy and ischaemic stroke’3
Blood-brain barrier function in response to SARS-CoV-2 and its spike protein3
Impact of SARS-CoV-2 on the nervous system3
Assessment of redox balance parameters among patients with acute ischaemic stroke3
SIGMAR1 gene-related neuromuscular disorders — what do we know?3
Role of neuroinflammation factors as potential biomarkers of epilepsy: a narrative review3
Acute polyneuropathy: a serious complication of levodopa/ /carbidopa intestinal gel treatment for Parkinson’s Disease3
0.056664943695068